<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03929952</url>
  </required_header>
  <id_info>
    <org_study_id>NIMAO/2018-01/AD-01</org_study_id>
    <nct_id>NCT03929952</nct_id>
  </id_info>
  <brief_title>Descriptive Pilot Study of the Effects of a Standardized Neuromodulation Program on Cortical Brain Function in Chronic Low Back Pain Patients</brief_title>
  <acronym>NEMOLOC</acronym>
  <official_title>Descriptive Pilot Study of the Effects of a Standardized Neuromodulation Program on Cortical Brain Function in Chronic Low Back Pain Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate neurofeedback-induced changes in brain function and the
      correlations between these changes and clinical scores by functional magnetic resonance
      imaging and electroencephalography in patients with low back pain.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Description of the cortical zone activated by neurofeedback</measure>
    <time_frame>Day 20</time_frame>
    <description>Measure taken by electroencephalography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Back Beliefs Questionnaire (BBQ)</measure>
    <time_frame>Day 20</time_frame>
    <description>Auto-Questionnaire with 14 items describing the patient beliefs about chronic low back pain. The higher the score, the more the beliefs are negative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fear Avoidance Beliefs Questionnaire (FABQ)</measure>
    <time_frame>Day 20</time_frame>
    <description>Auto-Questionnaire with 16 items describing apprehension and avoidance in relation to professional activities and physical activities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index (ODI)</measure>
    <time_frame>Day 20</time_frame>
    <description>Scale used to assess the functional disability of low back pain patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping Strategies Questionnaire (CSQ)</measure>
    <time_frame>Day 20</time_frame>
    <description>Auto-Questionnaire with 21 items evaluating coping strategies specific to pain and especially in low back pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>Day 20</time_frame>
    <description>Auto-Questionnaire with 14 items used in the detection of anxio-depressive disorders. The higher the score, the more the depression is severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scale of lumbar pain in Quebec</measure>
    <time_frame>Day 20</time_frame>
    <description>Autoquestionnaire with 20 items used to measure the functional repercussions of low back pain on simple actions of everyday life. The higher the score, the more low back pains have a significant functional impact.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tampa scale</measure>
    <time_frame>Day 20</time_frame>
    <description>Autoquestionnaire with 17 items used to estimate the level of kinesiophobia (fear and fear) related to pain that leads to avoidance of activities considered to cause or increase pain or to cause or aggravate an injury. The higher the score, the higher the level of kinesiophobia.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Low Back Pain</condition>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Chronic low back pain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neurofeedback treatment</intervention_name>
    <description>20 sessions of neurofeedback of 5 minutes each consisting of :
The patient is equipped with an electroencephalography headset. The feedback visual has the form of a candle flame and is modulated by alpha synchrony.
The height of the flame is proportional to the intensity of the patient's pain. The patient has to concentrate on the height of this flame by thought to modulate it and, at the same time, to decrease the intensity of his own pain.</description>
    <arm_group_label>Chronic low back pain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>functional magnetic resonance imaging (fMRI) scans</intervention_name>
    <description>The patient in alpha synchrony related state and in rating state will undergo an fMRI</description>
    <arm_group_label>Chronic low back pain</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with a wifi connexion at home

          -  Patient with the ability to modulate the height of the candle by thinking in the alpha
             synchrony test.

          -  Patient with chronic low back pain for more than six months with a visual analogue
             pain scale greater than 5 impacting activities of daily living, hobbies and work

          -  Patient having given free and informed consent and signed consent.

          -  Affected patient or beneficiary of a health insurance plan.

          -  Patient who is at least 18 years old (≥) and younger than 75 years old (&lt;).

        Exclusion Criteria:

          -  Pregnant or breastfeeding patient

          -  Patient with a contraindication to performing a fMRI scan: ferromagnetic implant in
             the body, piercing, claustrophobia, unable to remain in the scanner stationary for 40
             minutes

          -  Patient already included in another study

          -  Patient in a exclusion period determined by a previous study

          -  The subject is under the protection of justice, guardianship or curatorship.

          -  The subject refuses to sign the consent.

          -  It is not possible to give the subject informed information.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud Dupeyron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nîmes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arnaud Dupeyron</last_name>
    <phone>+33(0)4.66.68.34.59</phone>
    <email>arnaud.dupeyron@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nimes University Hospital</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Anissa Megzari</last_name>
      <phone>+33 (0)4.66.68.42.36</phone>
      <email>drc@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Arnaud Dupeyron, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabricio Pereira, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabel Tavares, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 24, 2019</study_first_submitted>
  <study_first_submitted_qc>April 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2019</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

